RIM
SRRA

RS Investment Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

RS Investment Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-24,508
Closed -$6.61M – 421
2016
Q1 		$6.61M Buy
24,508
+7,013
+40% +$2.24M 0.07% 255
2015
Q4 		$10.5M Buy
17,495
+1,914
+12% +$1.29M 0.09% 226
2015
Q3 		$12.8M Buy
+15,581
New +$17.6M 0.11% 218

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

RS Investment Management's SRRA Position: Q2 2016 in Review

RS Investment Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2016, closing a stake of 24,508 shares — an estimated $6.61M sold.

RS Investment Management first reported a position in SRRA in Q3 2015 and held it in 3 quarters. The position peaked at $12.8M in Q3 2015. 44 funds tracked by Wall St. Rank hold SRRA as of Q2 2016.

  • RS Investment Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • RS Investment Management sold 24,508 Sierra Oncology, Inc. Common Stock shares in Q2 2016, an estimated $6.61M.
  • RS Investment Management first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2015 and held it in 3 quarters.
  • RS Investment Management's Sierra Oncology, Inc. Common Stock position peaked at $12.8M in Q3 2015.
  • 44 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.